Cap-dependent translation initiation factor, eIF4E, is the target for Ouabain-mediated inhibition of HIF-1α
Authors:
- 1 May 2014
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 89 (1) , 20-30
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Quantitative High-Throughput Drug Screening Identifies Novel Classes of Drugs with Anticancer Activity in Thyroid Cancer Cells: Opportunities for RepurposingThe Journal of Clinical Endocrinology & Metabolism, 2012
- A Novel Two-Stage, Transdisciplinary Study Identifies Digoxin as a Possible Drug for Prostate Cancer TreatmentCancer Discovery, 2011
- Suppression of Hypoxia-Inducible Factor 1α (HIF-1α) by Tirapazamine Is Dependent on eIF2α Phosphorylation Rather Than the mTORC1/4E-BP1 PathwayPLOS ONE, 2010
- Hypoxia-Inducible Factors and the Response to Hypoxic StressMolecular Cell, 2010
- Q39, a quinoxaline 1,4-Di-N-oxide derivative, inhibits hypoxia-inducible factor-1α expression and the Akt/mTOR/4E-BP1 signaling pathway in human hepatoma cellsInvestigational New Drugs, 2010
- Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growthProceedings of the National Academy of Sciences, 2008
- Expression, purification and characterization of recombinant mouse translation initiation factor eIF4E as a dihydrofolate reductase (DHFR) fusion proteinProtein Expression and Purification, 2008
- Hypoxia-mediated Selective mRNA Translation by an Internal Ribosome Entry Site-independent MechanismJournal of Biological Chemistry, 2008
- The role of hypoxia-inducible factors in tumorigenesisCell Death & Differentiation, 2008
- CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF SignalingNeoplasia, 2006